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ABSTRACT
The article raises important issues regarding the use of diet and probiotics in prevention and treatment of vaginitis.
Vaginitis is defined as any condition with symptoms of abnormal vaginal discharge. The most common causes of vaginitis 
are vulvovaginal candidiasis (VVC), trichomoniasis and bacterial vaginosis (BV). Vaginitis has been linked to itching, burning, 
pain, discharge, irritation and also adverse reproductive and obstetric health outcomes. Moreover, microorganisms that 
build vaginal flora in the state of bacterial vaginosis are a source of cervicitis and endometritis (often in subclinical forms) 
and pelvic inflammatory disease (PID)
The proper diet and probiotics consumption may influence the composition of the gut microbiota, improve gut integrity, 
and have an impact on maintaining and recovering the normal vaginal microbiota.
Future studies and reviews investigating the role of diet and probiotics in changes to gut and vaginal microbiome need to 
focus on deciphering the mechanismus of host bacteria interaction in vulvovaginal health.
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INTRODUCTION
In adolescent girls and non-pregnant women, especially 
with a decrease in immunity, vaginitis, including fungal in-
fections, can occur, which clinically manifests as abnormal 
vaginal discharge, irritation, itching, burning, discomfort. 
Sexually transmitted diseases are a particularly problematic 
in women [1–9].
Vaginitis is a general term that refers to inflammation 
of the vaginal wall, generally caused by one of three dis-
orders: yeast infections, bacterial vaginosis or trichomo-
niasis. The normal bacterial flora of the vagina and cervix 
protect against the development of pathogenic strains, 
while abnormal flora tend to be the most common starting 
point for the development of infections.
During adolescence, bacterial vaginosis episodes af-
fect 3–7% of non-sexually related and 4–15% of sexually 
active girls 13–18 years of age. This is a significant problem, 
because the microorganisms that build vaginal flora in the 
state of bacterial vaginosis are a source of cervicitis and 
endometritis (often in subclinical forms) and pelvic inflam-
matory disease (PID) [1–8].
ETIOlOGy
Female genitalia are a natural biotope for commensal 
flora. Proper biocenosis of the genital environment deter-
mines protection against the development of inflammatory 
processes. Anatomical and physiological conditions of the 
genital organs — moisturizing and the proximity of the ure-
thra and anal opening - favor the development of infection. 
Genital inflammation is most often caused by neglecting 
hygiene, mechanical injury or infection (viruses, chlamydia, 
fungi, protozoa). A certain group of these inflammations also 
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occurs on an allergic basis (e.g. allergy to cleaning products). 
The most common causes of vaginitis are bacterial vaginosis 
(Bacterial vaginosis, BV), vulvar and vaginal candidiasis (Vul-
vovaginal candidiasis, VVC) and trichomoniasis. BV is involved 
in 40% to 50% of cases when the cause is identified, VVC ac-
counts for 20% to 25%, and trichomoniasis accounts for 15% 
to 20% of vaginitis. Non-infectious causes, including atrophic, 
irritating, inflammatory and allergic vaginosis occur less fre-
quently and account for 5% to 10% of cases of vaginitis [2]. 
The effectiveness of defense mechanisms and their mutual 
compensation is different in different periods of a woman’s 
life, which is hormonally determined [1–8, 10]. The vaginal 
microflora also changes during menstrual bleeding [11].
In the female newborn, who is still under the influence 
of estrogens from the period of intrauterine life, the pH of 
the vagina after colonization with acid-forming rods (Lacto-
bacillus acidophilus) is acidic. In the subsequent months of 
the girl’s life, the level of estrogen gradually decreases. The 
vaginal epithelium consists only of the basal and basal layers, 
without glycogen grains in the cells, which determines the 
development of acid-forming bacilli — the pH changes. Dur-
ing the so-called estrogenic silence, which lasts until the 
onset of puberty, the pH changes to neutral, at which time, 
the mixed bacterial flora of grains and sticks settles. A narrow 
vagina, adhesion of its walls, the presence of the hymen and 
the vaginal folds (plicae palmatae) constitute a mechanical 
compensation for the described lack of biochemical defenses 
during this period of life. During puberty, the concentration 
of estrogens increase and the vaginal epithelium becomes 
multilayered. The intermediate layer cells contain glycogen, 
which allows the development of acid-forming bacilli and pre-
vents the settlement of pathogenic microorganisms. A ma-
ture woman develops further defenses. These include the 
intensification of the process of exfoliation of genital epithelial 
cells, the formation of secretion, which is removed actively 
(e.g., epithelial shutter epithelium) or passively along with 
microorganisms and cell debris, as well as a specific pH value 
on individual genital floors. In girls who have not had sexual 
intercourse, inflammation of the internal genital organs oc-
curs relatively rarely, although descending (purulent tonsils, 
teeth) or through continuity (appendicitis) is also possible. 
Regardless of the age group analyzed, inflammatory prob-
lems in the genitals most often relate to vulvovaginitis [1–8]
This inflammation can be caused by viruses, chlamydia, 
bacteria, fungi (most often Candida Albicans), and vagi-
nal trichomes (Trichomonas Vaginalis). Some authors also 
recognise non-specific vulvovaginitis. Genital infections 
can be caused by endogenous vaginal bacterial flora or by 
exogenous bacterial flora (sexually transmitted and extrin-
sic) [1, 5, 7, 12].
In girls and women who have started sexual intercourse, 
an increase in vulvovaginitis and, as a result, an increase in 
internal genital inflammation due to the ascending route 
is observed [1, 5, 7, 12].
This review aimed to determine the role of proper diet 
and probiotics and prebiotics use in relation to therapy and 
profilaxis of vulvovaginal candidiasis (VVC) and bacterial 
vaginosis (BV) in non-pregnant women and girls.
THE ROlE OF DIET IN PREVENTION OF BV 
AND VVC
Numerous studies have proven that diet is a key modifi-
able factor affecting the composition of the intestinal mi-
croflora [12–21].
It is also known that educating patients in the field of bal-
ancing the diet (reducing the consumption of sweets, increas-
ing the consumption of vegetables, fruits and dairy products) 
has a significant role in the treatment of vaginitis [14].
The use of functional foods and supplements containing 
probiotics and prebiotics has a beneficial effect on genital 
inflammation [3, 9].
From the point of view of the proper function and preven-
tion of inflammation, it is important that the genital organs re-
ceive metabolism products from the blood: fats, proteins and 
carbohydrates. From metabolic products obtained through 
blood vessels, mucus is produced, which is necessary for 
proper vaginal hydration. Unfortunately, the predominance 
of carbohydrates, especially simple sugars, promotes the de-
velopment of abnormal vaginal flora and conditions become 
favorable for the development of yeast-like fungi [14–16].
To prevent inflammation, it is important to create 
an appropriate intestinal barrier. For protect the vaginal 
environment properly against excessive multiplication of 
pathogenic microorganisms, including yeast-like fungi, it is 
therefore important to have a properly balanced diet, low 
glycemic load, low fat, containing folic acid, vitamins D, E, 
C, A and beta carotene, as well as products rich in calcium 
and betaine [14–16].
An unbalanced diet can be a risk factor for BV. Women 
tend to be more exposed to BV if they have poor micronutri-
ent status, including vitamins A, E, D, C and beta carotene 
— indicating a lower fruit and vegetable intake. In recent 
years, scientists have found that the richer the diet is in 
nutrients, the lower the risk of apparent bacterial infection. 
Routine consumption of dairy products and fresh fruit and 
vegetables reduces the likelihood of vaginitis, while eating 
sweets increases the likelihood [14–16].
Sweets and other carbohydrate sources can affect the 
human glycemic response. Chronic and continuous expo-
sure to hyperglycemia after a meal can have an adverse 
effect on health and has been linked to oxidative damage 
by its reducing plasma antioxidant defense and increasing 
inflammation due to free radical production. It is possible 
that chronic exposure to diets with high energy value and 
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high energy density can affect host responses to bacterial 
colonization, particularly BV pathogenesis, through oxida-
tive stress and impaired immune function [16].
Yasmin et al. proved that increased dietary fat intake 
(39% of energy from fat), especially total fat, saturated fat 
and monounsaturated fat, can increase vaginal pH, thus 
increasing the risk of bacterial vaginosis. In addition, dietary 
fat may be a factor that inhibits the immune functions of the 
intestinal mucosa. It is likely that a high dietary fat intake 
may affect the mucosal immune system and thus increase 
the risk of bacterial infections associated with BV. The studies 
cited did not show a relationship between BV and carbohy-
drate or protein intake, and this means that high fat intake 
is a predictor of BV independent of energy intake [16–18].
A proper calcium supply is also important in preventing 
inflammation in women and girls. Genital infections are 
more common in cases where there are low levels of cal-
cium in the body. The sources of calcium are milk and dairy 
products such as cheese or yogurt, but also legumes (e.g. 
white beans), seeds (e.g. sesame) and dark green vegetables 
(such as broccoli or spinach). Yasmin et al. proved significant 
inverse relationships between severe BV and calcium intake, 
as well as with folic acid, and vitamin E [18].
With the weakening of the immune system in women 
and girls, the likelihood of infection increases, and vitamin 
E (a powerful antioxidant) and folic acid can improve the 
immune response, thereby reducing the risk of BV [18, 19].
But since there is a relationship between taking ascorbic 
acid and boosting the immune system, the diet must be rich in 
products containing vitamin C. In addition, it has been shown 
that subclinical iron deficiency (measured based on soluble 
transferrin receptor) can be a significant predictor of BV [19].
An unbalanced diet can be a risk factor for BV, because 
it affects the microbial population of the mucosal surface 
in the digestive and reproductive tracts. In turn, bacterial 
colonization of the intestine can act as a reservoir for the 
vaginal microflora. Antonio et al. found agreement between 
Lactobacillus species in the rectum and vagina, suggesting 
that the rectum may serve as a potential source of vaginal 
colonization. The authors suggest that the adhesion proper-
ties of specific bacteria in the rectum may determine which 
species adhere to the vaginal epithelium [20].
In a recently published study, Tuddenham et al. proved 
that lower energy-adjusted intake of betaine was associated 
with an increased risk of molecular-BV. Betaine might have 
direct effects on the vaginal microenvironment or may be 
mediated through the gut microbiota. Betaine can be found 
in the diet in such products as bran and wheatgerm, goji 
berries, spinach or beets [21].
Additional studies are needed to confirm that higher in-
take of selected dietary ingredients, such as betaine, reduces 
the risk of BV and BV-related symptoms [21].
THE ROlE OF PROBIOTICS IN THE 
PREVENTION AND TREATMENT OF BV  
AND VVC
Probiotics are live microorganisms that, when adminis-
tered in adequate amounts, confer a health benefit to the 
host [20]. Probiotics can be ingested as part of the diet or 
in supplement form [23, 24].
Probiotics have been reported to be useful when used 
either vaginally or orally [25].
The biochemical activity of probiotics (as a natural food 
ingredient or added as starter cultures) affects not only 
the nutritional, dietary and organoleptic characteristics of 
the product, but also has preventive and therapeutic ef-
fects. Probiotics are microorganisms, mainly lactic acid bac-
teria, that can colonize the human digestive tract. They may 
contain individual strains of lactic acid bacteria (Lactobacillus 
spp., Streptococcus spp.), strains of yeast (Saccharomyces 
spp.), mold cultures (Aspergillus spp.), or also lactic acid bac-
teria, together with selected yeast strains. Probiotics have 
a positive effect on gastrointestinal transit time and ensure 
the proper development of the microflora inhabiting the 
body. The word ‚probiotic’ comes from Greek and means „fit 
for life”. This term was first used in 1965 by Lilly and Stillwell, 
who described probiotics as substances produced by micro-
organisms that stimulate human and animal growth. Fuller 
added to the name in 1989 by defining that: „probiotics are 
live, bacterial food additives that improve the functioning 
of the host’s digestive tract” [5].
In order to call a given bacterial strain a probiotic strain, 
it must come from the natural healthy microflora of the large 
intestine, be an absolute or relative anaerobic, and belong to 
a specific genus and species that has been assigned to it by 
molecular methods. It is advisable for it to be resistant to the 
acidic pH of gastric juice, bile salts and digestive enzymes. It 
should not exhibit pathogenic or toxic properties, and it 
is also recommended that it exhibits antagonistic activity 
against harmful gastrointestinal bacteria, have the ability 
to attach to the surface and colonize the colon, produces 
antibacterial substances, and have genetic stability. Active 
growth and division, as well as high lactic acid yield during 
fermentation of monosaccharides, disaccharides and com-
plex sugars, is also important. Its positive effects should be 
scientifically confirmed and must retain all their properties 
in processing and storage. Most of these features allow 
probiotic bacteria to survive in the digestive tract and enter 
the large intestine, where they perform their functions. It has 
been proved that consuming probiotics has positive effects 
on the management of some gastrointestinal conditions 
(Irritable Bowel Syndrome, diarrhea). Probiotics can also 
counteract the pathogenic activity of microflora in the in-
testines, which penetrate as a result of non-compliance 
with food hygiene [9].
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Probiotics are used after antibiotic therapy, and to pro-
duce functional food (especially milk products) and sup-
plements [25–27].
The positive effects of probiotics on the immune system 
can be used to treat intestinal infections caused by HIV that 
penetrate the lining of the large intestine. The protective 
function is fulfilled by the previously mentioned biofilm 
constituting a natural immune barrier, and also by antibiot-
ics produced by the intestinal microflora and the free radi-
cal lactactoxidase system. Probiotics can stimulate cellular 
and humoral immune responses. Many studies proved that 
regulated use of probiotics, administered both orally and 
vaginally, are effective in the prevention and treatment of 
vaginal infections such as BV and VVC [23, 24, 28].
Bacterial vaginosis is characterized by a reduction or 
depletion of lactobacilli and overgrowth of Gardnerella vagi-
nalis, Mycoplasma hominis, Prevotella species, and other 
pathogenic anaerobic bacteria [9].
The Lactobacillus species produces lactic and acetic 
acid and hydrogen peroxide (H2O2), maintains the vaginal 
pH around 4.5 or less, hampers the growth of pathogenic 
bacteria and Candida albicans, and is thus considered pro-
tective against VVC and BV [28, 29].
Due to the production of lactic acid by probiotics, the 
electro-chemical potential of cell membranes and intracel-
lular protein denaturation of harmful microflora are neutral-
ized. Hydrogen peroxide is toxic to pathogens. Probiotics 
destroy pathogens as a result of their competing for nutri-
ents and for receptors in the mucosa and epithelium. They 
also produce bacteriocins that remove pathogens from 
the digestive tract. They are heterogeneous chemicals that 
inhibit the activity of pathogenic bacteria — Staphylococ-
cus aureus, Salmonella enteritidis, Bacillus cereus, or Pseu-
domonas aeruginosa, are mainly produced by Lactobacillus 
acidophilus. Bastani confirmed the potential efficacy of lac-
tobacilli as a non-chemotherapeutic means to restore and 
maintain normal urogenital flora, and showed that probiotic 
bacteria especially L. acidophilus, L. rhamnosus GR-1 and L. 
fermentum RC-14 when administered over 10^8 CFU for 
2 months can most appropriately normalize vaginal flora, 
help cure the existing infection and prevent recurrence of 
BV. Longer periods of probiotic administration may be use-
ful for long-term control of BV relapses after conventional 
therapy with metronidazole [25].
According to Xie HY et al., probiotics used as adjuvant 
therapy may increase the incidence of short-term clinical 
and mycological cure and reduce the relapse rate within 
one month, but not act as a long-term cure. The benefits 
and drawbacks of probiotics in vulvar and vaginal candidi-
asis in non-pregnant women should be considered carefully.
There is a need to conduct large-scale, long-term, rand-
omized control tests with adequate blindness of participants 
and staff, and to do so in different age groups. Where probiot-
ics are intended to be used as adjunct agents to conventional 
drugs, a placebo should be used in the control group. The ef-
fect of different strains should also be checked, and possible 
effects from different routes of administration observed [30].
THE IMPORTANCE OF PREBIOTICS AND 
SyNBIOTICS IN THE DIET
To create a positive environment for probiotics, it is im-
portant to provide prebiotics that support the development 
of probiotic strains. Prebiotics are defined as non-digestible 
food ingredients that selectively stimulate the growth or 
activity of one or a specified number of types of bacteria in 
the colon that favorably affect the health of the host. Prebi-
otics can be introduced artificially into foods to improve the 
nutritional and health value, e.g. inulin, fructooligosaccha-
rides, lactulose, or galactose and β-glucan derivatives. They 
are a breeding ground for probiotics, stimulate their growth 
and, unlike them, do not contain microorganisms. Prebiot-
ics are not digested by endogenous enzymes in the hu-
man body, remain practically undigested as they reach the 
colon, where they are completely fermented and broken 
down by saccharolytic bacteria (e.g. Bifidobacterium) [13].
The basic criteria that prebiotics should meet are that 
they should lower the pH of the digestive tract and should 
not undergo hydrolysis or absorption through the gastroin-
testinal tract. Their task is also to stimulate the growth of lac-
tic acid bacteria and inhibit the activity of harmful intestinal 
microflora. It has been proved that prebiotic consumption 
is associated with growth of Bifidobacterium, Lactobacillus 
and lactic acid bacteria [31]. Researchers suggest that con-
sumption of prebiotics has a positive impact not only on 
gut microbial composition, but also on health outcomes, 
because probiotics produce beneficial metabolites [13].
Studies have shown that ingestion of prebiotics signifi-
cantly affects the composition of the intestinal microflora 
and its metabolic activity. This is due to the modulation of 
lipid metabolism, increased calcium absorption, their impact 
on the immune system and modification of intestinal func-
tion. Prebiotics occur naturally in over 36,000 plant-derived 
products, including garlic (9–16%), chicory (13–20%), ar-
tichokes (15–20%), asparagus (10–15%), onions (2–6%), 
wheat (1–4%) and bananas (0.3–0.7%) [9]. Artificially pro-
duced prebiotics include lactulose, galactooligosaccharides, 
fructooligosaccharides, malotoligosaccharides, cyclodex-
trins and lactosaccharose. Synbiotics are a combination of 
pre- and probiotic and these have a synergistic effect. They 
affect the development of beneficial intestinal microflora 
due to stimulation of probiotics with prebiotics. They also 
inhibit the development of pathogenic bacterial flora in 
the intestines. Synbiotics contribute to reducing the con-
centration of unwanted metabolites in the body, inactivat-
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ing nitrosamines and carcinogens, as well as preventing 
putrefaction in the intestines and preventing constipation 
and diarrhea of various etiologies. Synbiotics also reduce 
harmful microflora (Clostridium perfringensi of other en-
dopathogens) while multiplying beneficial bacteria. They 
lower cholesterol and blood pressure and are used to treat 
patients with liver disease [9]. They improve the absorp-
tion of magnesium and phosphorus and calcium, which, 
as mentioned, has a beneficial effect on the prevention of 
inflammation in gynecology [1, 4, 5, 7–9].
SUMMARy
Gynecologists, obstetricians, general practitioners and 
dieticians should share their findings, and also raise aware-
ness among the general population as to the importance 
of optimal nutrition, probiotics and prebiotic use to prevent 
infections of the genital tract, reduce associated disease, and 
maintain reproductive health.
Future reviews investigating dietary and biochemical in-
dicators of nutritional status, and the role of diet in changes 
to gut and vaginal microbiome need to focus on further 
elucidating the biological mechanisms for these findings.
Further research is needed on the long-term influence of 
diets and probiotics use on vulva and vagina health before 
clinical recommendations can be made.
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